Healthcare provider profile · identity verified

Raymond Gregory Mason, MD

Allopathic & Osteopathic Physicians|Family Medicine · WOOSTER, OH · NPI 1609874403

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Raymond Gregory Mason, MD received $17.23 in general payments during 2025 across 1 reported records.

Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 55 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 95 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$17.23

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$17.23	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$17.23	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$17.23	1	2025
Source payment records 2025-05-12 · Lilly USA, LLC · $17.23 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$17.23	1	2025
Source payment records 2025-05-12 · Lilly USA, LLC · $17.23 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	95	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	55	15
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	95	12
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	16	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	588	170
Atorvastatin Calcium	Atorvastatin Calcium	574	166
Lisinopril	Lisinopril	494	136
Pantoprazole Sodium	Pantoprazole Sodium	408	106
Levothyroxine Sodium	Levothyroxine Sodium	375	98
Simvastatin	Simvastatin	309	76
Gabapentin	Gabapentin	306	60
Omeprazole	Omeprazole	301	80
Losartan Potassium	Losartan Potassium	280	77
Metoprolol Succinate	Metoprolol Succinate	245	68
Rosuvastatin Calcium	Rosuvastatin Calcium	242	76
Trazodone Hcl	Trazodone Hcl	237	64
Metformin Hcl	Metformin Hcl	235	57
Lorazepam	Lorazepam	233	37
Hydrochlorothiazide	Hydrochlorothiazide	232	63
Metformin Hcl Er	Metformin Hcl	230	58
Albuterol Sulfate Hfa	Albuterol Sulfate	208	83
Metoprolol Tartrate	Metoprolol Tartrate	203	63
Glimepiride	Glimepiride	197	55
Alprazolam	Alprazolam	188	30
Escitalopram Oxalate	Escitalopram Oxalate	174	42
Furosemide	Furosemide	168	48
Allopurinol	Allopurinol	167	42
Sertraline Hcl	Sertraline Hcl	159	41
Pravastatin Sodium	Pravastatin Sodium	149	36
Tamsulosin Hcl	Tamsulosin Hcl	149	42
Eliquis	Apixaban	146	29
Potassium Chloride	Potassium Chloride	136	38
Pioglitazone Hcl	Pioglitazone Hcl	131	34
Meloxicam	Meloxicam	118	34
Fluticasone Propionate	Fluticasone Propionate	112	40
Montelukast Sodium	Montelukast Sodium	106	23
Carvedilol	Carvedilol	101	24
Bupropion Xl	Bupropion Hcl	99	31
Citalopram Hbr	Citalopram Hydrobromide	96	27
Mounjaro	Tirzepatide	95	12
Tizanidine Hcl	Tizanidine Hcl	94	35
Clopidogrel	Clopidogrel Bisulfate	91	32
Duloxetine Hcl	Duloxetine Hcl	88	18
Xarelto	Rivaroxaban	84	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	25
Doxycycline Hyclate	Doxycycline Hyclate	75	59
Tramadol Hcl	Tramadol Hcl	75	19
Famotidine	Famotidine	72	24
Atenolol	Atenolol	69	22
Zolpidem Tartrate	Zolpidem Tartrate	69	suppressed
Ozempic	Semaglutide	64	15
Amitriptyline Hcl	Amitriptyline Hcl	57	18
Synthroid	Levothyroxine Sodium	56	17
Jardiance	Empagliflozin	55	15
Mirtazapine	Mirtazapine	55	12
Ezetimibe	Ezetimibe	54	13
Paroxetine Hcl	Paroxetine Hcl	54	12
Prednisone	Prednisone	54	30
Pregabalin	Pregabalin	53	suppressed
Enalapril Maleate	Enalapril Maleate	52	suppressed
Warfarin Sodium	Warfarin Sodium	52	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	13
Esomeprazole Magnesium	Esomeprazole Magnesium	51	suppressed
Spironolactone	Spironolactone	51	11
Finasteride	Finasteride	50	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	15
Lovastatin	Lovastatin	46	14
Fluoxetine Hcl	Fluoxetine Hcl	45	14
Oxybutynin Chloride Er	Oxybutynin Chloride	43	16
Buspirone Hcl	Buspirone Hcl	42	13
Celecoxib	Celecoxib	42	suppressed
Symbicort	Budesonide/Formoterol Fumarate	40	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	12
Alendronate Sodium	Alendronate Sodium	39	16
Hydralazine Hcl	Hydralazine Hcl	39	13
Olmesartan Medoxomil	Olmesartan Medoxomil	39	12
Clonazepam	Clonazepam	38	suppressed
Glipizide	Glipizide	38	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Amoxicillin	Amoxicillin	35	27
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Glipizide Er	Glipizide	33	suppressed
Lansoprazole	Lansoprazole	32	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	31	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Valsartan	Valsartan	29	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Diazepam	Diazepam	27	suppressed
Methylprednisolone	Methylprednisolone	27	25
Triamcinolone Acetonide	Triamcinolone Acetonide	27	13
Meclizine Hcl	Meclizine Hcl	26	14
Nystop	Nystatin	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Cephalexin	Cephalexin	24	23
Propranolol Hcl	Propranolol Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	24	suppressed
Baclofen	Baclofen	23	suppressed
Gemfibrozil	Gemfibrozil	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Januvia	Sitagliptin Phosphate	22	suppressed
Linzess	Linaclotide	22	suppressed
Varenicline Tartrate	Varenicline Tartrate	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Nystatin	Nystatin	21	13
Advair Diskus	Fluticasone Propion/Salmeterol	20	suppressed
Colchicine	Colchicine	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Janumet Xr	Sitagliptin Phos/Metformin Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluconazole	Fluconazole	16	13
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Metolazone	Metolazone	13	suppressed
Ramipril	Ramipril	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Estradiol	Estradiol	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Irbesartan	Irbesartan	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$17.23 · 1 records	Lilly USA, LLC	MOUNJARO, ZEPBOUND	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error